Sarcoma  >>  mipetresgene autoleucel (TBI-1301)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mipetresgene autoleucel (TBI-1301) / Takara
NCT03250325: Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma

Hourglass Jan 2020 - Jan 2020 : P1/2 trial in unresectable progressive/recurrent synovial sarcoma
Completed
1/2
8
Japan
TBI-1301, Cyclophosphamide
Takara Bio Inc.
Synovial Sarcoma
01/20
03/22

Download Options